{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:00:32Z","timestamp":1787760032580,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 15K09279"],"award-info":[{"award-number":["JP 15K09279"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12072-021-10176-9","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T16:02:48Z","timestamp":1617379368000},"page":"791-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Hiroshi","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Makabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Akihisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-3191","authenticated-orcid":false,"given":"Toshio","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"10176_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jhep.2017.11.024","volume":"68","author":"RMM van Aerts","year":"2018","unstructured":"van Aerts RMM, van de Laarschot LFM, Banales JM, Drenth JPH. Clinical management of polycystic liver disease. J Hepatol 2018;68:827\u2013837","journal-title":"J Hepatol"},{"key":"10176_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10157-012-0741-0","volume":"17","author":"T Mochizuki","year":"2013","unstructured":"Mochizuki T, Tsuchiya K, Nitta K. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol 2013;17:317\u2013326","journal-title":"Clin Exp Nephrol"},{"key":"10176_CR3","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/hep.29708","volume":"67","author":"TV Masyuk","year":"2018","unstructured":"Masyuk TV, Masyuk AI, LaRusso NF. Polycystic liver disease: the interplay of genes causative for hepatic and renal cystogenesis. Hepatology 2018;67:2462\u20132464","journal-title":"Hepatology"},{"key":"10176_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4254\/wjh.v12.i3.72","volume":"12","author":"ZY Zhang","year":"2020","unstructured":"Zhang ZY, Wang ZM, Huang Y. Polycystic liver disease: classification, diagnosis, treatment process, and clinical management. World J Hepatol 2020;12:72\u201383","journal-title":"World J Hepatol"},{"key":"10176_CR5","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","volume":"272","author":"T Mochizuki","year":"1996","unstructured":"Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996;272:1339\u20131342","journal-title":"Science"},{"key":"10176_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ng.860","volume":"43","author":"SV Fedeles","year":"2011","unstructured":"Fedeles SV, Tian X, Gallagher AR, Mitobe M, Nishio S, Lee SH, Cai Y, Geng L, Crews CM, Somlo S. A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet 2011;43:639\u2013647","journal-title":"Nat Genet"},{"key":"10176_CR7","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3748\/wjg.v19.i23.3543","volume":"19","author":"MA Lantinga","year":"2013","unstructured":"Lantinga MA, Gevers TJ, Drenth JP. Evaluation of hepatic cystic lesions. World J Gastroenterol. 2013;19:3543\u201354.","journal-title":"World J Gastroenterol"},{"key":"10176_CR8","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.3748\/wjg.v19.i35.5775","volume":"19","author":"B Abu-Wasel","year":"2013","unstructured":"Abu-Wasel B, Walsh C, Keough V, Molinari M. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013;19:5775\u20135786","journal-title":"World J Gastroenterol"},{"key":"10176_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/hep.1840110619","volume":"11","author":"PA Gabow","year":"1990","unstructured":"Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990;11:1033\u20131037","journal-title":"Hepatology"},{"key":"10176_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000501021","volume":"44","author":"H Kataoka","year":"2019","unstructured":"Kataoka H, Ono K, Mochizuki T, Hanafusa N, Imai E, Hishida A, Nitta K. A Body mass index-based cross-classification approach for the assessment of prognostic factors in chronic kidney disease progression. Kidney Blood Press Res 2019;44:362\u2013383","journal-title":"Kidney Blood Press Res"},{"key":"10176_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1681\/ASN.2017050483","volume":"29","author":"E Cornec-Le Gall","year":"2018","unstructured":"Cornec-Le Gall E, Torres VE, Harris PC. Genetic complexity of autosomal dominant polycystic kidney and liver diseases. J Am Soc Nephrol 2018;29:13\u201323","journal-title":"J Am Soc Nephrol"},{"key":"10176_CR12","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/ndt\/gfw008","volume":"31","author":"FT Chebib","year":"2016","unstructured":"Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE, El-Zoghby ZM. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2016;31:952\u2013960","journal-title":"Nephrol Dial Transplant"},{"key":"10176_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/jcm9010146","volume":"9","author":"H Kataoka","year":"2020","unstructured":"Kataoka H, Fukuoka H, Makabe S, Yoshida R, Teraoka A, Ushio Y, Akihisa T, Manabe S, Sato M, Mitobe M, Tsuchiya K, Nitta K, Mochizuki T. Prediction of renal prognosis in patients with autosomal dominant polycystic kidney disease using pkd1\/pkd2 mutations. J Clin Med 2020;9:146","journal-title":"J Clin Med"},{"key":"10176_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s10157-019-01736-3","volume":"23","author":"T Mochizuki","year":"2019","unstructured":"Mochizuki T, Teraoka A, Akagawa H, Makabe S, Akihisa T, Sato M, Kataoka H, Mitobe M, Furukawa T, Tsuchiya K, Nitta K. Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients. Clin Exp Nephrol 2019;23:1022\u20131030","journal-title":"Clin Exp Nephrol"},{"key":"10176_CR15","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/hep.24036","volume":"52","author":"JP Drenth","year":"2010","unstructured":"Drenth JP, Chrispijn M, Nagorney DM, Kamath PS, Torres VE. Medical and surgical treatment options for polycystic liver disease. Hepatology 2010;52:2223\u20132230","journal-title":"Hepatology"},{"key":"10176_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s10157-019-01830-6","volume":"24","author":"S Muto","year":"2020","unstructured":"Muto S, Ando M, Nishio S, Hanaoka K, Ubara Y, Narita I, Kamura K, Mochizuki T, Tsuchiya K, Tsuruya K, Horie S. The relationship between liver cyst volume and QOL in Japanese ADPKD patients. Clin Exp Nephrol 2020;24:314\u2013322","journal-title":"Clin Exp Nephrol"},{"key":"10176_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165:710\u2013718","journal-title":"Am J Epidemiol"},{"key":"10176_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1478-3231.2007.01595.x","volume":"28","author":"IA Hoevenaren","year":"2008","unstructured":"Hoevenaren IA, Wester R, Schrier RW, McFann K, Doctor RB, Drenth JP, Everson GT. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease. Liver Int 2008;28:264\u2013270","journal-title":"Liver Int"},{"key":"10176_CR19","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/00000658-199703000-00008","volume":"225","author":"JF Gigot","year":"1997","unstructured":"Gigot JF, Jadoul P, Que F, Van Beers BE, Etienne J, Horsmans Y, Collard A, Geubel A, Pringot J, Kestens PJ. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management? Ann Surg 1997;225:286\u2013294","journal-title":"Ann Surg"},{"key":"10176_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/ki.2011.411","volume":"81","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int 2012;81:577\u2013585","journal-title":"Kidney Int"},{"issue":"155\u2013164","key":"10176_CR21","first-page":"e156","volume":"13","author":"MC Hogan","year":"2015","unstructured":"Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M, Moore CG, Schrier RW. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol 2015;13(155\u2013164):e156","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10176_CR22","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1093\/ndt\/gfr139","volume":"26","author":"H Kataoka","year":"2011","unstructured":"Kataoka H, Ohara M, Honda K, Mochizuki T, Nitta K. Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy. Nephrol Dial Transplant 2011;26:3937\u20133943","journal-title":"Nephrol Dial Transplant"},{"key":"10176_CR23","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Ferec C, Le Meur Y. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 2013;24:1006\u20131013","journal-title":"J Am Soc Nephrol"},{"key":"10176_CR24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/01.ASN.0000013300.11876.37","volume":"13","author":"S Rossetti","year":"2002","unstructured":"Rossetti S, Burton S, Strmecki L, Pond GR, San Millan JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 2002;13:1230\u20131237","journal-title":"J Am Soc Nephrol"},{"key":"10176_CR25","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1172\/JCI64313","volume":"122","author":"K Hopp","year":"2012","unstructured":"Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan HF, Gainullin VG, Rossetti S, Torres VE, Harris PC. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Invest 2012;122:4257\u20134273","journal-title":"J Clin Invest"},{"key":"10176_CR26","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/hep.27331","volume":"60","author":"AI Masyuk","year":"2014","unstructured":"Masyuk AI, Gradilone SA, LaRusso NF. Calcium signaling in cilia and ciliary-mediated intracellular calcium signaling: are they independent or coordinated molecular events? Hepatology 2014;60:1783\u20131785.","journal-title":"Hepatology"},{"key":"10176_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1053\/j.gastro.2006.07.003","volume":"131","author":"AI Masyuk","year":"2006","unstructured":"Masyuk AI, Masyuk TV, Splinter PL, Huang BQ, Stroope AJ, LaRusso NF. Cholangiocyte cilia detect changes in luminal fluid flow and transmit them into intracellular Ca2+ and cAMP signaling. Gastroenterology 2006;131:911\u2013920","journal-title":"Gastroenterology"},{"key":"10176_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2353\/ajpath.2008.070293","volume":"172","author":"D Alvaro","year":"2008","unstructured":"Alvaro D, Onori P, Alpini G, Franchitto A, Jefferson DM, Torrice A, Cardinale V, Stefanelli F, Mancino MG, Strazzabosco M, Angelico M, Attili A, Gaudio E. Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. Am J Pathol 2008;172:321\u2013332","journal-title":"Am J Pathol"},{"key":"10176_CR29","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1093\/hmg\/10.21.2385","volume":"10","author":"W Lu","year":"2001","unstructured":"Lu W, Shen X, Pavlova A, Lakkis M, Ward CJ, Pritchard L, Harris PC, Genest DR, Perez-Atayde AR, Zhou J. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet 2001;10:2385\u20132396","journal-title":"Hum Mol Genet"},{"key":"10176_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","volume":"4","author":"C Bergmann","year":"2018","unstructured":"Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers 2018;4:50","journal-title":"Nat Rev Dis Primers"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10176-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10176-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10176-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T05:07:14Z","timestamp":1626584834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10176-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10176"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10176-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Toshio Mochizuki and Ken Tsuchiya received travel fees and honoraria for lectures from Otsuka Pharmaceutical Co. Toshio Mochizuki and Hiroshi Kataoka belong to an endowed department sponsored by Otsuka Pharmaceutical Co., Chugai Pharmaceutical Co., Kyowa Hakko Kirin Co., and JMS Co.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2008 and approved by the Research Ethics Committee of Tokyo Women\u2019s Medical University (No. 196B).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Research (Ethics)"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trials Registration"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from all patients for being included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Informed consent was obtained from all patients to participate in the study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all patients to be included in this manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}}]}}